100.00% -23.50

Assertio Holdings Inc (ASRT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ASRT Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Assertio Holdings Inc Stock (ASRT) Company Profile

Assertio Holdings Inc

Healthcare (1081)

(224) 419-7106

100 S. SAUNDERS ROAD, LAKE FOREST, IL

Prossima data di guadagno

Ultimi documenti SEC

ASRT's Discussions on Twitter

Compare ASRT vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ASRT Assertio Holdings Inc	0.00	151.86M	102.16M	-35.69M	-7.08M	-5.7327
TAK Takeda Pharmaceutical Co Adr	17.65	55.69B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.26	43.77B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.19	36.19B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	78.42	32.25B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	530.12	26.29B	3.17B	1.29B	1.01B	27.09

Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-09	Downgrade	H.C. Wainwright	Buy → Neutral
2024-07-26	Iniziato	Maxim Group	Buy
2024-07-03	Iniziato	H.C. Wainwright	Buy
2022-11-07	Iniziato	Lake Street	Buy
2018-11-30	Downgrade	Mizuho	Buy → Neutral

Assertio Holdings Inc Borsa (ASRT) Ultime notizie

Assertio Holdings Inc Azioni (ASRT) Dati Finanziari

Assertio Holdings Inc (ASRT)

Assertio Holdings Inc Stock (ASRT) Company Profile

Compare ASRT vs TAK, HLN, TEVA, ZTS, UTHR

Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades

Assertio Holdings Inc Borsa (ASRT) Ultime notizie

ASRT5746402 Bond Coupon Profile — Rate & Payments - TradingView

ASRT5746402 Bond Profile — Key Metrics - TradingView

Press Release: Assertio Provides Update on Garda Therapeutics Tender Process - Moomoo

Assertio Beats Investor Suit Over Drug, Merger Claims - Law360

Assertio Investors Fail to Advance Suit Over Spectrum Merger (1) - Bloomberg Law News

Assertio (ASRT) Small-Cap Growth Virtual Investor Conference Summary - Quartr

Assertio (ASRT) Proxy Filing Summary - Quartr

ASRT Stock Drops After-Hours On Discounted Buyout Deal — Retail Calls It A ‘Robbery’ - Stocktwits

Assertio (ASRT) Q2 2024 earnings summary - Quartr

Assertio Holdings (ASRT) Holds Steady Near Resistance as Trading Volume Remains SubduedSector ETF Flow - Bölüm Sonu Canavarı

Assertio Holdings (NASDAQ: ASRT) common stock struck from Nasdaq list - Stock Titan

Assertio Holdings (ASRT) Holds Steady Amid Consolidation at $23.50Gamma Flip Level - dars.gov.et

Assertio Deadline Alert - TMX Newsfile

ASRT CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile

Zydus Lifesciences Completes Acquisition of Assertio Holdings - Machine Maker

[15-12G] Assertio Holdings, Inc. SEC Filing - Stock Titan

ASRT Q1 2026 Earnings: Steep EPS Miss Amid Silent Revenue DisclosuresLong-Term Guidance - dars.gov.et

Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market - Indian Pharma Post

Zydus Lifesciences Completes Acquisition of Assertio; Nasdaq Delisting Confirmed - Digital Health News

Assertio Holdings Inc (ASRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Assertio Holdings Inc (ASRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Assertio Holdings Inc (ASRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Zydus Acquires Assertio for Oncology Growth - Chemical Industry Digest

[EFFECT] Assertio Holdings, Inc. SEC Filing - Stock Titan

Assertio Holdings Inc (ASRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Zydus Completes USD 166.4 Million Acquisition of US-Based Assertio Holdings - Medical Dialogues

Key facts: Assertio appoints two directors; Nasdaq halt, delisting - TradingView

Assertio Holdings Completes Merger with Zydus Lifesciences; Shareholders Receive $23.50 Per Share in Cash 1 - Minichart

Zydus Lifesciences Completes Acquisition of US-Based Assertio Holdings - marketscreener.com

Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million - inkl

Assertio completes $23.50 per share merger with Zydus - Investing.com UK

Assertio (ASRT) director fully cashes out shares and options in Zydus $23.50-per-share merger - Stock Titan

Zydus buys Assertio (ASRT); EVP Schlessinger equity cashed out at $23.50 - Stock Titan

Assertio Holdings (ASRT) director exits as Zydus cash merger pays $23.50 - Stock Titan

Assertio (ASRT) director’s shares and options cashed out in $23.50 Zydus buyout - Stock Titan

Assertio (ASRT) COO exits stock, options and RSUs in $23.50-per-share cash merger - Stock Titan

Assertio (ASRT) CEO exits all shares and awards in $23.50-per-share cash merger - Stock Titan

Assertio (ASRT) director cashes out shares and options in Zydus merger - Stock Titan

Assertio (ASRT) director fully cashed out as $23.50-per-share merger closes - Stock Titan

CFO Ajay Patel exits Assertio (ASRT) stake in $23.50-per-share merger - Stock Titan

Zydus completes Assertio acquisition, notes repurchase rights triggered - scanx.trade

Assertio Amends 2027 Convertible Notes After Merger; Holders Get Cash-Only Conversion, Put Right - TradingView

Assertio Holdings (ASRT) completes merger; deregisters $250M shelf capacity - Stock Titan

Assertio Holdings (ASRT) deregisters S-4s after $23.50 cash tender and merger - Stock Titan

Acquirer completes Assertio deal; ASRT removed registered shares after $23.50 tender - Stock Titan

Assertio completes $23.50 per share merger with Zydus By Investing.com - Investing.com Australia

Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 - marketscreener.com

Zydus buys Assertio (NASDAQ: ASRT) in $23.50‑per‑share all‑cash deal - Stock Titan

Zydus deal gives Assertio holders $23.50 cash per share - Stock Titan

Zydus Lifesciences completes acquisition of Assertio - ET Manufacturing

Zydus Lifesciences shares in focus on completing acquisition of Assertio Holdings; key details - Upstox

Assertio Holdings Inc Azioni (ASRT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ASRT